Taming Out-of-Control Specialty Pharmaceutical Costs

Palma, Steve
May 2010
Benefits & Compensation Digest;May2010, Vol. 47 Issue 5, p1
The article discusses the state of the U.S. pharmaceutical industry in 2010. It states that though many drugs have been developed that have mitigated previously untreatable diseases, the costs involved are staggering. As a result, healthcare has become equally expensive for private, corporate, and federal entities. Part of the problem is also blamed on inconsistent and complicated billing methods, constantly changing payment schemes, and inconsistent contracts. To address this, it suggests consistent billing procedures, management, auditing processes.


Related Articles

  • Pharma's role in cost control. FLAUM, SANDER A. // Medical Marketing & Media;Sep2014, Vol. 49 Issue 9, p58 

    The article offers the author's insights on the role of pharmaceuticals companies in controling the costs of medicine in the U.S. Topics discussed by the author include the negative reaction of top medical brands to generic competition like Advair Diskus from Glaxo SmithKline (GSK), price...

  • A healthy decision.  // BusinessToday;Aug2015, Issue 201, p1 

    The article focuses on the steps taken by the government of Oman to reduce the cost in healthcare. Topics discussed include revision and reduction in prices of drugs from five therapeutic groups, including gastrointestinal, cardiovascular, and dermatology drugs, to prevent the increase in...

  • Don't Fall Asleep Monitoring Rx Coverage--You May Wake Up to a Nightmare. Cahn, Linda // Benefits Magazine;Dec2015, Vol. 52 Issue 12, p34 

    The article discusses the cost challenges and key contract terms that plans should address to control plan costs in the pharmaceutical industry. Topics discussed include the increases in prices of drugs, the entrance of new brand drugs, and concerns on newly approved specialty drugs. Also...

  • The Prescription-Drug Problem. Steinbrook, Robert // New England Journal of Medicine;3/14/2002, Vol. 346 Issue 11, p790 

    Discusses problems caused by the high cost of prescription drugs, including the expense of drugs for those who can afford to pay for them and the limited access to medications for those who cannot. How the elderly and those with chronic illnesses are affected; Two studies in this issue that...

  • Improving Insulin Distribution and Administration Safety Using Lean Six Sigma Methodologies. . Yamamoto, Jay; Abraham, Divya; Malatestinic, Bill // Hospital Pharmacy;Mar2010, Vol. 45 Issue 3, p212 

    Purpose: To utilize Lean Six Sigma in a hospital environment to improve insulin medication safety, improve the efficiency of insulin delivery, and reduce costs by analyzing the dispensing and administration process. Methods: A Six Sigma team from a pharmaceutical manufacturer and a...

  • How to start a diabetes management service. Shah, Monica // Drug Topics;9/12/2005, Vol. 149 Issue 17, p36 

    This article provides tips on how to start a diabetes screening and management service program. Before implementing any patient care service, the needs of the patients and other healthcare providers within the community should be assessed. The strengths and weaknesses of the pharmacists should...

  • The New Global Villains.  // Policy;Spring2001, Vol. 17 Issue 3, p6 

    Features the article on the pharmaceutical industry around the globe. Costs of prescription drugs; Implications of political opportunism; Expenditure on general medical care.

  • Medicaid plans target prescription drug costs.  // Drug Store News;2/18/2002, Vol. 24 Issue 2, p1 

    Reports on the plan of Medicaid to deal with prescription drug costs in the U.S. Problems facing Medicaid; Cost effectiveness of the plan; Increase in drug prices; Implications of the plan.

  • Patients' attempts to cut medication costs.  // Pharmacy Today;Apr2015, Vol. 21 Issue 4, p13 

    Statistics are given regarding the measures taken by patients to cut their medication costs which include buying of prescription drugs from foreign countries, use of alternative therapies, and demand for cheap medication to doctors.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics